Bio-Rad Laboratories, Inc. (BIO)
USD 323.94
(-4.12%)
USD 323.94
(-4.12%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.04 Billion USD | -3.43% |
| 2022 | 1.08 Billion USD | -5.78% |
| 2021 | 1.15 Billion USD | 12.11% |
| 2020 | 1.02 Billion USD | -0.05% |
| 2019 | 1.02 Billion USD | -0.5% |
| 2018 | 1.03 Billion USD | -2.53% |
| 2017 | 1.05 Billion USD | 3.58% |
| 2016 | 1.02 Billion USD | 7.08% |
| 2015 | 954.96 Million USD | -7.15% |
| 2014 | 1.02 Billion USD | 1.93% |
| 2013 | 1 Billion USD | 12.5% |
| 2012 | 896.93 Million USD | 1.61% |
| 2011 | 882.73 Million USD | 9.32% |
| 2010 | 807.47 Million USD | 5.55% |
| 2009 | 765.05 Million USD | -5.35% |
| 2008 | 808.33 Million USD | 24.64% |
| 2007 | 648.51 Million USD | 15.33% |
| 2006 | 562.32 Million USD | 5.86% |
| 2005 | 531.18 Million USD | 9.16% |
| 2004 | 486.6 Million USD | 15.96% |
| 2003 | 419.63 Million USD | 12.77% |
| 2002 | 372.11 Million USD | 6.58% |
| 2001 | 349.15 Million USD | -2.76% |
| 2000 | 359.06 Million USD | 31.43% |
| 1999 | 273.2 Million USD | 19.09% |
| 1998 | 229.4 Million USD | -0.43% |
| 1997 | 230.4 Million USD | 8.17% |
| 1996 | 213 Million USD | 5.6% |
| 1995 | 201.7 Million USD | 12.31% |
| 1994 | 179.6 Million USD | -2.29% |
| 1993 | 183.8 Million USD | -4.02% |
| 1992 | 191.5 Million USD | 15.08% |
| 1991 | 166.4 Million USD | 11.68% |
| 1990 | 149 Million USD | 24.27% |
| 1989 | 119.9 Million USD | 22.85% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 274.45 Million USD | 2.37% |
| 2024 Q3 | 296.43 Million USD | 14.1% |
| 2024 Q2 | 255.42 Million USD | -6.94% |
| 2023 Q3 | 244.73 Million USD | -10.31% |
| 2023 Q2 | 272.86 Million USD | -9.2% |
| 2023 FY | 1.04 Billion USD | -3.43% |
| 2023 Q4 | 268.1 Million USD | 9.55% |
| 2023 Q1 | 300.5 Million USD | 7.93% |
| 2022 Q2 | 275.76 Million USD | 6.01% |
| 2022 Q1 | 260.13 Million USD | -11.52% |
| 2022 FY | 1.08 Billion USD | -5.78% |
| 2022 Q4 | 278.42 Million USD | -0.91% |
| 2022 Q3 | 280.99 Million USD | 1.9% |
| 2021 FY | 1.15 Billion USD | 12.11% |
| 2021 Q1 | 299.76 Million USD | 5.21% |
| 2021 Q2 | 276.81 Million USD | -7.66% |
| 2021 Q3 | 280.63 Million USD | 1.38% |
| 2021 Q4 | 294.01 Million USD | 4.77% |
| 2020 Q4 | 284.91 Million USD | 10.56% |
| 2020 Q3 | 257.71 Million USD | 6.82% |
| 2020 Q2 | 241.24 Million USD | -0.72% |
| 2020 Q1 | 242.99 Million USD | -10.41% |
| 2020 FY | 1.02 Billion USD | -0.05% |
| 2019 Q2 | 251.37 Million USD | -1.48% |
| 2019 Q4 | 271.23 Million USD | 8.68% |
| 2019 Q1 | 255.15 Million USD | -3.94% |
| 2019 Q3 | 249.56 Million USD | -0.72% |
| 2019 FY | 1.02 Billion USD | -0.5% |
| 2018 Q3 | 250.44 Million USD | -2.88% |
| 2018 Q4 | 265.61 Million USD | 6.06% |
| 2018 FY | 1.03 Billion USD | -2.53% |
| 2018 Q1 | 258.55 Million USD | -7.99% |
| 2018 Q2 | 257.87 Million USD | -0.26% |
| 2017 Q3 | 258.14 Million USD | -6.35% |
| 2017 Q4 | 281.02 Million USD | 8.86% |
| 2017 Q1 | 244.42 Million USD | -11.94% |
| 2017 FY | 1.05 Billion USD | 3.58% |
| 2017 Q2 | 275.65 Million USD | 12.77% |
| 2016 Q4 | 277.56 Million USD | 10.42% |
| 2016 FY | 1.02 Billion USD | 7.08% |
| 2016 Q2 | 257.7 Million USD | 8.14% |
| 2016 Q1 | 238.3 Million USD | -4.31% |
| 2016 Q3 | 251.37 Million USD | -2.46% |
| 2015 FY | 954.96 Million USD | -7.15% |
| 2015 Q2 | 239.39 Million USD | 1.54% |
| 2015 Q3 | 230.78 Million USD | -3.6% |
| 2015 Q4 | 249.03 Million USD | 7.91% |
| 2015 Q1 | 235.75 Million USD | -11.64% |
| 2014 FY | 1.02 Billion USD | 1.93% |
| 2014 Q4 | 266.82 Million USD | 4.5% |
| 2014 Q2 | 251.55 Million USD | -1.28% |
| 2014 Q1 | 254.81 Million USD | -5.77% |
| 2014 Q3 | 255.33 Million USD | 1.5% |
| 2013 Q1 | 237.85 Million USD | -4.42% |
| 2013 Q2 | 248.55 Million USD | 4.5% |
| 2013 Q3 | 255.15 Million USD | 2.66% |
| 2013 FY | 1 Billion USD | 12.5% |
| 2013 Q4 | 270.43 Million USD | 5.99% |
| 2012 FY | 896.93 Million USD | 1.61% |
| 2012 Q2 | 214.59 Million USD | -4.29% |
| 2012 Q1 | 224.21 Million USD | -0.36% |
| 2012 Q4 | 248.85 Million USD | 18.91% |
| 2012 Q3 | 209.27 Million USD | -2.48% |
| 2011 FY | 882.73 Million USD | 9.32% |
| 2011 Q3 | 222.25 Million USD | -1.2% |
| 2011 Q2 | 224.95 Million USD | 6.87% |
| 2011 Q4 | 225.03 Million USD | 1.25% |
| 2011 Q1 | 210.49 Million USD | -5.16% |
| 2010 FY | 807.47 Million USD | 5.55% |
| 2010 Q2 | 200.13 Million USD | 3.22% |
| 2010 Q1 | 193.88 Million USD | -6.95% |
| 2010 Q3 | 191.52 Million USD | -4.3% |
| 2010 Q4 | 221.93 Million USD | 15.88% |
| 2009 FY | 765.05 Million USD | -5.35% |
| 2009 Q4 | 208.37 Million USD | 7.89% |
| 2009 Q3 | 193.13 Million USD | 3.8% |
| 2009 Q2 | 186.07 Million USD | 4.85% |
| 2009 Q1 | 177.46 Million USD | -9.28% |
| 2008 Q3 | 189.34 Million USD | 0.34% |
| 2008 FY | 808.33 Million USD | 24.64% |
| 2008 Q4 | 195.61 Million USD | 3.31% |
| 2008 Q1 | 177.14 Million USD | -12.67% |
| 2008 Q2 | 188.71 Million USD | 6.53% |
| 2007 Q4 | 202.84 Million USD | 34.48% |
| 2007 Q2 | 154.3 Million USD | 9.8% |
| 2007 Q1 | 140.53 Million USD | -9.79% |
| 2007 FY | 648.51 Million USD | 15.33% |
| 2007 Q3 | 150.83 Million USD | -2.25% |
| 2006 Q4 | 155.78 Million USD | 13.77% |
| 2006 Q3 | 136.93 Million USD | -3.18% |
| 2006 Q2 | 141.43 Million USD | 10.36% |
| 2006 Q1 | 128.16 Million USD | -8.93% |
| 2006 FY | 562.32 Million USD | 5.86% |
| 2005 FY | 531.18 Million USD | 9.16% |
| 2005 Q4 | 140.73 Million USD | 7.1% |
| 2005 Q3 | 131.41 Million USD | -0.99% |
| 2005 Q2 | 132.72 Million USD | 5.07% |
| 2005 Q1 | 126.32 Million USD | -11.48% |
| 2004 Q2 | 115.74 Million USD | 0.98% |
| 2004 Q4 | 142.71 Million USD | 22.22% |
| 2004 Q3 | 116.76 Million USD | 0.88% |
| 2004 Q1 | 114.61 Million USD | -0.5% |
| 2004 FY | 486.6 Million USD | 15.96% |
| 2003 Q4 | 115.19 Million USD | 10.63% |
| 2003 Q3 | 104.13 Million USD | 2.33% |
| 2003 Q2 | 101.75 Million USD | 3.26% |
| 2003 Q1 | 98.54 Million USD | -4.73% |
| 2003 FY | 419.63 Million USD | 12.77% |
| 2002 FY | 372.11 Million USD | 6.58% |
| 2002 Q4 | 103.43 Million USD | 10.74% |
| 2002 Q3 | 93.4 Million USD | 4.6% |
| 2002 Q2 | 89.29 Million USD | 3.95% |
| 2002 Q1 | 85.89 Million USD | -13.63% |
| 2001 FY | 349.15 Million USD | -2.76% |
| 2001 Q4 | 99.45 Million USD | 16.15% |
| 2001 Q1 | 81.02 Million USD | -13.47% |
| 2001 Q3 | 85.62 Million USD | 3.11% |
| 2001 Q2 | 83.04 Million USD | 2.49% |
| 2000 Q1 | 89.27 Million USD | -6.81% |
| 2000 Q4 | 93.63 Million USD | 9.56% |
| 2000 Q3 | 85.46 Million USD | -5.76% |
| 2000 Q2 | 90.68 Million USD | 1.57% |
| 2000 FY | 359.06 Million USD | 31.43% |
| 1999 Q1 | 58.7 Million USD | -1.68% |
| 1999 Q3 | 60.4 Million USD | 3.6% |
| 1999 FY | 273.2 Million USD | 19.09% |
| 1999 Q4 | 95.8 Million USD | 58.61% |
| 1999 Q2 | 58.3 Million USD | -0.68% |
| 1998 Q2 | 57.2 Million USD | 1.96% |
| 1998 FY | 229.4 Million USD | -0.43% |
| 1998 Q4 | 59.7 Million USD | 6.04% |
| 1998 Q1 | 56.1 Million USD | -11.09% |
| 1998 Q3 | 56.3 Million USD | -1.57% |
| 1997 Q1 | 55.7 Million USD | -3.97% |
| 1997 FY | 230.4 Million USD | 8.17% |
| 1997 Q4 | 63.1 Million USD | 14.73% |
| 1997 Q3 | 55 Million USD | -2.65% |
| 1997 Q2 | 56.5 Million USD | 1.44% |
| 1996 Q2 | 52.2 Million USD | 1.56% |
| 1996 Q1 | 51.4 Million USD | -4.64% |
| 1996 FY | 213 Million USD | 5.6% |
| 1996 Q4 | 58 Million USD | 13.06% |
| 1996 Q3 | 51.3 Million USD | -1.72% |
| 1995 Q3 | 48.8 Million USD | -5.24% |
| 1995 Q2 | 51.5 Million USD | 8.19% |
| 1995 FY | 201.7 Million USD | 12.31% |
| 1995 Q1 | 47.6 Million USD | -1.65% |
| 1995 Q4 | 53.9 Million USD | 10.45% |
| 1994 FY | 179.6 Million USD | -2.29% |
| 1994 Q3 | 44.4 Million USD | 2.07% |
| 1994 Q2 | 43.5 Million USD | 0.46% |
| 1994 Q1 | 43.3 Million USD | -10.72% |
| 1994 Q4 | 48.4 Million USD | 9.01% |
| 1993 FY | 183.8 Million USD | -4.02% |
| 1993 Q1 | 44.7 Million USD | -8.21% |
| 1993 Q3 | 44.4 Million USD | -4.1% |
| 1993 Q4 | 48.5 Million USD | 9.23% |
| 1993 Q2 | 46.3 Million USD | 3.58% |
| 1992 FY | 191.5 Million USD | 15.08% |
| 1992 Q4 | 48.7 Million USD | 7.51% |
| 1992 Q3 | 45.3 Million USD | -15.96% |
| 1992 Q2 | 53.9 Million USD | 24.77% |
| 1992 Q1 | 43.2 Million USD | -5.05% |
| 1991 FY | 166.4 Million USD | 11.68% |
| 1991 Q3 | 40.8 Million USD | 0.0% |
| 1991 Q1 | 39.4 Million USD | -0.51% |
| 1991 Q2 | 40.8 Million USD | 3.55% |
| 1991 Q4 | 45.5 Million USD | 11.52% |
| 1990 Q3 | 37 Million USD | -2.37% |
| 1990 FY | 149 Million USD | 24.27% |
| 1990 Q1 | 34.5 Million USD | 3.92% |
| 1990 Q4 | 39.6 Million USD | 7.03% |
| 1990 Q2 | 37.9 Million USD | 9.86% |
| 1989 Q1 | - USD | 100.0% |
| 1989 Q2 | 29.5 Million USD | 0.0% |
| 1989 Q3 | 29.5 Million USD | 0.0% |
| 1989 Q4 | 33.2 Million USD | 12.54% |
| 1989 FY | 119.9 Million USD | 22.85% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Abbott Laboratories | 15.71 Billion USD | 93.333% |
| Allurion Technologies Inc. | 120.57 Million USD | -768.795% |
| Artivion, Inc. | 223.43 Million USD | -368.841% |
| Avanos Medical, Inc. | 375.5 Million USD | -178.975% |
| Butterfly Network, Inc. | 162.46 Million USD | -544.781% |
| Butterfly Network, Inc. | 162.46 Million USD | -544.781% |
| Boston Scientific Corporation | 7.47 Billion USD | 85.992% |
| Perspective Therapeutics, Inc. | 17.42 Million USD | -5911.42% |
| CONMED Corporation | 564.24 Million USD | -85.656% |
| Edwards Lifesciences Corporation | 3.09 Billion USD | 66.109% |
| Paragon 28, Inc. | 210.1 Million USD | -398.596% |
| Glaukos Corporation | 367.83 Million USD | -184.787% |
| Globus Medical, Inc. | 887.16 Million USD | -18.079% |
| Inspire Medical Systems, Inc. | 568.49 Million USD | -84.268% |
| Integer Holdings Corporation | 250.95 Million USD | -317.419% |
| Medtronic plc | 16.12 Billion USD | 93.505% |
| Nevro Corp. | 389.36 Million USD | -169.039% |
| Owlet, Inc. | 51.21 Million USD | -1945.237% |
| Penumbra, Inc. | 590.87 Million USD | -77.287% |
| Vicarious Surgical Inc. | 80.66 Million USD | -1198.626% |
| Smith & Nephew plc | 3.46 Billion USD | 69.785% |
| Sonendo, Inc. | 68.46 Million USD | -1430.052% |
| STERIS plc | 1.4 Billion USD | 25.194% |
| Stryker Corporation | 9.2 Billion USD | 88.625% |
| Vapotherm, Inc. | 66.02 Million USD | -1486.596% |
| Zimmer Biomet Holdings, Inc. | 3.27 Billion USD | 68.024% |